Do You Actually Need a Vitamin D Supplement? What the Big Trials Show

Last reviewed: 31 October 2026 · Written by SD, pharmacist · No products were supplied and no commission is earned from this review.

The short answer

Vitamin D is one of the most-taken supplements in Australia, and for years it looked like a near-miracle in observational studies: people with higher blood levels had less cancer, heart disease, depression and infection. Then the big randomised trials arrived. When tens of thousands of healthy adults were given vitamin D or a placebo for five years, most of those benefits disappeared.

One explanation is that low vitamin D can be a marker of poor health as well as a consequence of limited intake or sun exposure; observational associations do not establish causation. People who are unwell, inactive, overweight or indoors a lot tend to have lower levels. Topping up a number on a blood test doesn’t undo those things.

That doesn’t make vitamin D useless. If you’re genuinely deficient, or you’re in a higher-risk group (housebound, in residential aged care, very little sun exposure, pregnant), it’s worth taking. For generally healthy adults without an indication for supplementation, taking extra vitamin D has not shown broad preventive benefits. Outdoor time alone does not establish vitamin D adequacy, and sun exposure should follow Australian skin-cancer prevention advice. The 2024 Endocrine Society guideline reached the same conclusion: it suggests against routine supplementation above the recommended intake, and against routine blood testing, in healthy adults under 75.^[1]

How does it work?

Vitamin D is really a hormone precursor. Your skin makes it from UVB sunlight; food (oily fish, eggs, fortified margarine and milk) supplies only a little. The liver converts it to 25-hydroxyvitamin D, the form measured in blood tests, and the kidneys then make the active hormone, calcitriol.

Calcitriol’s main job is to help you absorb calcium and phosphate from the gut, which keeps bones mineralised. Severe deficiency causes rickets in children and osteomalacia (soft, painful bones) and muscle weakness in adults. Vitamin D receptors are also found on immune cells and many other tissues, which is why researchers hoped it would prevent infections, cancer and autoimmune disease.

In Australia, a blood level below 50 nmol/L is generally considered deficient, and below 30 nmol/L is moderate-to-severe deficiency. Note that the US uses ng/mL: 20 ng/mL equals 50 nmol/L.^[22]

What the human trials show

Cancer, heart disease and living longer

Study	Who and what	Main finding (vitamin D vs. placebo)
VITAL, 2019[2]	25,871 US adults aged 50+, 2,000 IU a day, about 5 years	No reduction in cancer (HR 0.96) or major cardiovascular events (HR 0.97). Cancer deaths: HR 0.83, not statistically significant.
D-Health, 2022[3]	21,315 Australians aged 60–84, 60,000 IU once a month, 5 years	No reduction in deaths from any cause (HR 1.04). Cardiovascular events were 9% lower, but this was not statistically significant (HR 0.91, 95% CI 0.81–1.01).[4]
Zhang 2019 meta-analysis[5]	52 trials, 75,454 people	No effect on all-cause or cardiovascular deaths. Cancer deaths 16% lower (RR 0.84).
Keum 2022 meta-analysis[6]	RCTs on cancer incidence and death	No effect on getting cancer (RR 0.99). Cancer deaths 13% lower with daily dosing (RR 0.87), but not with large occasional doses.

Pharmacist’s take: these are some of the biggest, best-run supplement trials ever done, and they are clear: routine vitamin D has not convincingly reduced cancer incidence or overall major cardiovascular events in populations mostly not selected for deficiency. The D-Health cardiovascular estimate remains compatible with a modest benefit or no effect. The cancer-death signal is interesting and fairly consistent, but it’s a secondary outcome and the absolute difference is small. It isn’t a reason on its own to start taking vitamin D.

Bones, fractures and falls

Study	Who and what	Main finding
Bolland 2018 meta-analysis[7]	81 RCTs, 53,537 people, vitamin D alone	No effect on total fractures (RR 1.00), hip fractures (RR 1.11), falls (RR 0.97) or bone density. Higher doses didn’t help either.
VITAL fracture study, 2022[8]	25,871 adults aged 50+, 2,000 IU a day	No significant reduction in total, non-vertebral or hip fractures. Baseline-level subgroup analyses were also null, but very few participants had severe deficiency; this does not test treatment of osteomalacia or marked deficiency.
Yao 2019 meta-analysis[9]	6 RCTs, 49,282 people, vitamin D (400–800 IU) plus calcium (1,000–1,200 mg) daily	Any fracture 6% lower (RR 0.94); hip fracture 16% lower (RR 0.84). Vitamin D alone: no benefit.
Sanders 2010[10]	2,256 older Australian women, 500,000 IU once a year	More falls (15% higher rate) and more fractures (26% higher), especially in the 3 months after each dose.

Pharmacist’s take: this is the surprise for most people. Vitamin D on its own doesn’t prevent fractures in community-dwelling adults. The benefit appears with calcium as well, and mostly in older, frailer people, including those in residential aged care. The Victorian once-a-year trial is a useful warning: a huge dose can do harm, so steady daily dosing is the safer pattern.

Colds, flu and chest infections

Earlier 2017 and 2021 meta-analyses suggested a small reduction in acute respiratory infections.^[11][12] The updated 2025 analysis included 46 trials and 64,086 participants contributing primary-outcome data. Its overall result did not reach statistical significance (OR 0.94, 95% CI 0.88–1.00). Daily-dose and other subgroup signals did not establish that treatment effects differed between groups.^[20] Vitamin D should therefore not be presented as a proven cold-prevention supplement.

The UK CORONAVIT test-and-treat trial also found no reduction in respiratory infections or COVID-19.^[13] Correcting deficiency remains a separate clinical indication. For treatment rather than prevention, see our review of zinc for colds: it may shorten a cold, although the evidence is uncertain.

Type 2 diabetes in people with prediabetes

The D2d trial gave 4,000 IU a day to 2,423 people with prediabetes. Diabetes was 12% less common, but this was not statistically significant (HR 0.88, 95% CI 0.75–1.04).^[14] When D2d was pooled with two similar trials, vitamin D reduced progression to diabetes by 15% (HR 0.85), about 3 fewer cases per 100 people over 3 years.^[15] The pooled result supports a possible modest benefit as an adjunct to lifestyle changes. The 2024 guideline suggests supplementation for high-risk prediabetes; it does not replace weight management, physical activity or usual diabetes-prevention care.^[1]

Autoimmune disease and depression

In VITAL, 2,000 IU a day cut new autoimmune diseases (such as rheumatoid arthritis, psoriasis and thyroid autoimmunity) by 22% (HR 0.78, borderline significance).^[16] At seven years, including two years after supplementation stopped, the cumulative estimate was null (HR 0.98). Newly confirmed cases also weakened the original treatment-period result, so this remains uncertain rather than proof of an effect that lasts only during treatment.^[17] For depression, VITAL found no difference in new or recurrent depression or mood scores among 18,353 adults (HR 0.97).^[18]

D3 vs. D2, daily vs. big doses

Option	Evidence	Verdict
Vitamin D3 (cholecalciferol)	Used in almost all major trials. Raises blood levels more effectively than D2.[19]	The default choice
Vitamin D2 (ergocalciferol)	Plant/fungal form. Less effective at raising levels, especially as occasional large doses.[19]	Fine for vegans if D3 isn’t acceptable (vegan D3 from lichen also exists)
Daily dosing	Some cancer-mortality analyses favour daily dosing, but respiratory-infection prevention remains uncertain.[6][20] For adults aged 50+ who have an indication for supplementation, the Endocrine Society prefers lower daily doses over intermittent higher doses.[1]	The safest, best-supported pattern
Large weekly/monthly doses	Monthly 60,000 IU (D-Health) was safe but showed no mortality benefit.[3]	Acceptable when prescribed, e.g. to improve adherence
Once-a-year mega doses	500,000 IU yearly increased falls and fractures.[10]	Avoid
Capsule vs. drops vs. spray	All raise levels; absorption is better taken with a meal containing some fat	Choose what you’ll actually take
Combined with K2, magnesium etc.	No established evidence that routine add-on K2 or magnesium improves clinical outcomes for generally healthy vitamin D users	Use additional nutrients only for an identified need

Safety and interactions: a pharmacist’s checklist

• Common doses: 1,000–2,000 IU (25–50 µg) a day is generally well tolerated when indicated, but is not a universal daily requirement. The Australian/NZ upper level for adults is 80 µg (3,200 IU) a day from all sources,^[21] unless your doctor prescribes more to treat a deficiency.
• Toxicity is rare but real: it causes high blood calcium (nausea, vomiting, thirst, passing lots of urine, confusion, kidney stones). It usually needs months of very high intakes (typically above 10,000 IU a day) or a product/dosing error, such as confusing a weekly dose with a daily one.
• Thiazide diuretics (hydrochlorothiazide, indapamide, chlorthalidone): these reduce calcium loss in urine. Combined with high-dose vitamin D and calcium they can push calcium too high, so get your levels checked.
• Digoxin: high calcium increases the risk of digoxin-related heart rhythm problems. Avoid high doses without medical supervision.
• Medicines that lower vitamin D levels: carbamazepine, phenytoin, phenobarbital, primidone, rifampicin and long-term corticosteroids. People on these may need more vitamin D; ask your doctor about testing.
• Medicines that block absorption: orlistat, cholestyramine/colestipol and liquid paraffin (mineral oil). Use medicine-specific spacing rather than one rule for all products. Orlistat product information advises a vitamin supplement at least 2 hours before or after orlistat, for example at bedtime. Ask a pharmacist about bile-acid sequestrants and other products.^[23][24]
• Prescription active vitamin D (calcitriol, alfacalcidol): don’t add an over-the-counter supplement without checking with your doctor.
• Talk to your doctor or pharmacist first if you have:
  • Sarcoidosis or another granulomatous disease (these make extra active vitamin D).
  • Primary hyperparathyroidism or high blood calcium.
  • A history of calcium kidney stones.
  • Moderate-to-severe kidney disease (the formulation and monitoring need individual assessment; an activated form is not automatically required).
  • A pregnancy, or you’re breastfeeding: supplementation is often advised, but follow your antenatal care team on dose.

Who should consider it?

• People with a confirmed deficiency (below 50 nmol/L). Your doctor will choose the dose and usually recheck after about 3 months.
• People who get very little sun: housebound people, aged-care residents, night-shift workers, people who cover most of their skin for cultural or religious reasons, and people with darker skin living in southern Australia, especially through winter.
• Older people at risk of falls or fractures, particularly in residential care: vitamin D with calcium (or adequate dietary calcium) is where the fracture evidence is strongest.
• Adults aged 75 and older: the Endocrine Society suggests empiric supplementation, partly because of a possible small reduction in deaths in this age group.^[1]
• Pregnancy: as advised by your antenatal care team.
• High-risk prediabetes: worth discussing with your doctor as an add-on to lifestyle changes, not a replacement for them.
• Extra supplementation is often not needed: generally healthy adults under 75 who meet recommended intake and have no established indication for extra supplementation. Routine screening is not recommended; testing should follow clinical risk factors and Australian guidance.

How to judge a vitamin D product

We don’t recommend specific brands. Instead, check any product against these criteria:

• Vitamin D3 (cholecalciferol) as the active ingredient, unless you need a vegan option.
• Dose stated in both µg and IU: 1 µg = 40 IU. Most people need no more than 1,000–2,000 IU (25–50 µg) a day unless prescribed. Be careful with high-strength weekly products: don’t take them daily.
• Australian regulatory identification: AUST L identifies a listed medicine; AUST R identifies a registered medicine. An ordinary AUST L listing does not mean the TGA individually checked that the product works before sale, and is not independent batch testing.^[25] Be cautious with imported products bought online, where dose errors have caused toxicity.
• Calcium only if you need it: if you’re older and don’t get about 1,000–1,300 mg of calcium a day from food, a combined product may make sense. Otherwise plain vitamin D is enough.
• No “mega-dose” claims or unnecessary extras: do not assume added K2, magnesium or “immune blends” improve outcomes; additional ingredients need their own indication and evidence.

Our evidence grade

Claim	Grade	Why
Corrects deficiency and prevents rickets/osteomalacia	A: strong	Well established; the reason vitamin D supplements exist
Prevents fractures in older people (with calcium)	B: moderate	Meta-analysis of large RCTs: modest reduction, mostly in older and institutionalised people
Prevents acute respiratory infections	No clear overall benefit	2025 update: 46 trials, 64,086 participants; overall result did not reach statistical significance; subgroup signals do not establish who benefits
Reduces cancer deaths	C: limited but promising	Consistent signal in meta-analyses with daily dosing, but a secondary outcome
Slows progression from prediabetes to diabetes	C: limited but promising	Pooled 3 RCTs show 15% lower risk; the largest trial alone was not significant
Prevents autoimmune disease	C: limited but promising	Original trial signal weakened by additional case confirmation; seven-year cumulative estimate was null
General health in people who aren’t deficient	No established broad benefit	Substantial trial evidence is mostly null; this is a benefit verdict, not weak study design or low certainty
Prevents fractures or falls (vitamin D alone, healthy adults)	Not supported	Large RCTs and meta-analyses show no effect
Prevents cancer, heart attack or stroke	Not supported	VITAL was null; D-Health major cardiovascular events were inconclusive, with a possible modest benefit
Prevents depression	Not supported	VITAL-DEP: no effect in 18,353 adults

How we grade the evidence → · More reviews: creatine: benefits and hair loss · zinc for colds · magnesium glycinate for sleep

References

1. Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2024;109(8):1907–1947. doi:10.1210/clinem/dgae290
2. Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33–44. doi:10.1056/NEJMoa1809944
3. Neale RE, Baxter C, Romero BD, et al. The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality. Lancet Diabetes Endocrinol. 2022;10(2):120–128. doi:10.1016/S2213-8587(21)00345-4
4. Thompson B, Waterhouse M, English DR, et al. Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial. BMJ. 2023;381:e075230. doi:10.1136/bmj-2023-075230
5. Zhang Y, Fang F, Tang J, et al. Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ. 2019;366:l4673. doi:10.1136/bmj.l4673
6. Keum N, Chen QY, Lee DH, et al. Vitamin D supplementation and total cancer incidence and mortality by daily vs. infrequent large-bolus dosing strategies: a meta-analysis of randomised controlled trials. Br J Cancer. 2022;127(5):872–878. doi:10.1038/s41416-022-01850-2
7. Bolland MJ, Grey A, Avenell A. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. 2018;6(11):847–858. doi:10.1016/S2213-8587(18)30265-1
8. LeBoff MS, Chou SH, Ratliff KA, et al. Supplemental vitamin D and incident fractures in midlife and older adults. N Engl J Med. 2022;387(4):299–309. doi:10.1056/NEJMoa2202106
9. Yao P, Bennett D, Mafham M, et al. Vitamin D and calcium for the prevention of fracture: a systematic review and meta-analysis. JAMA Netw Open. 2019;2(12):e1917789. doi:10.1001/jamanetworkopen.2019.17789
10. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303(18):1815–1822. doi:10.1001/jama.2010.594
11. Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. doi:10.1136/bmj.i6583
12. Jolliffe DA, Camargo CA, Sluyter JD, et al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol. 2021;9(5):276–292. doi:10.1016/S2213-8587(21)00051-6
13. Jolliffe DA, Holt H, Greenig M, et al. Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT). BMJ. 2022;378:e071230. doi:10.1136/bmj-2022-071230
14. Pittas AG, Dawson-Hughes B, Sheehan P, et al. Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med. 2019;381(6):520–530. doi:10.1056/NEJMoa1900906
15. Pittas AG, Kawahara T, Jorde R, et al. Vitamin D and risk for type 2 diabetes in people with prediabetes: a systematic review and meta-analysis of individual participant data from 3 randomized clinical trials. Ann Intern Med. 2023;176(3):355–363. doi:10.7326/M22-3018
16. Hahn J, Cook NR, Alexander EK, et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022;376:e066452. doi:10.1136/bmj-2021-066452
17. Costenbader KH, Cook NR, Lee IM, et al. Vitamin D and marine n-3 fatty acids for autoimmune disease prevention: outcomes two years after completion of a double-blind, placebo-controlled trial. Arthritis Rheumatol. 2024;76(6):973–983. doi:10.1002/art.42811
18. Okereke OI, Reynolds CF, Mischoulon D, et al. Effect of long-term vitamin D3 supplementation vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: a randomized clinical trial. JAMA. 2020;324(5):471–480. doi:10.1001/jama.2020.10224
19. Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357–1364. doi:10.3945/ajcn.111.031070
20. Jolliffe DA, Camargo CA Jr, Sluyter JD, et al. Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data. Lancet Diabetes Endocrinol. 2025;13:307–320. doi:10.1016/S2213-8587(24)00348-6
21. Australian Government. Nutrient Reference Values: vitamin D. Adult upper intake level. Accessed 31 October 2026.
22. Royal College of Pathologists of Australasia. Vitamin D: testing and interpretation. Accessed 31 October 2026.
23. Australian Commission on Safety and Quality in Health Care. Orlistat Viatris: medicine information. Accessed 31 October 2026.
24. Australian Commission on Safety and Quality in Health Care. OsteVit-D One-A-Week: medicine information. Accessed 31 October 2026.
25. Australian Government Department of Health. About medicines: listed and registered medicines. Accessed 31 October 2026.

This article is general educational information, not personal medical advice. Talk to your doctor or pharmacist before starting a supplement, especially if you take regular medicines, have kidney disease, sarcoidosis or high calcium, or are pregnant or breastfeeding. Evidence for Supplements does not accept payment or free products from supplement manufacturers for reviews.

Medical Disclaimer · Editorial Policy · Corrections Policy

Follow the evidence each Friday

Get our Friday Evidence Update: new human research, practical context and the limitations that matter. Subscribe by email. Unsubscribe at any time.

Email *

Subscribe

Subscription form is not available at the moment

Read our Privacy Policy.